CVE-2019-14454
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
- Record
CVE-2019-14454- CVSS 3.1
- 9.8 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 7.5 High
AV:N/AC:L/Au:N/C:P/I:P/A:P - Updated
- 2026-11-02
CVE List No score
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
- Record
CVE-2019-14454- Updated
- 2026-11-02
EUVDEUVD-2019-5643 No score
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
- Record
EUVD-2019-5643- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-vrmm-5gjp-xrg8 No score
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
- Record
GHSA-vrmm-5gjp-xrg8- Updated
- 2026-11-02
OSV
SuiteCRM 7.11.x and 7.10.x before 7.11.8 and 7.10.20 is vulnerable to vertical privilege escalation.
- Record
CVE-2019-14454- CVSS 3.1
- 9.8 Critical
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD, OSV |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2019-14454 is a critical vulnerability (CVSS 9.8) in Salesagility Suitecrm, published October 2, 2019. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.51%, the 74th percentile. No source names a fixed version.